Your browser doesn't support javascript.
loading
Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: A multicenter study in 3132 memory clinic patients.
Biesbroek, J Matthijs; Coenen, Mirthe; DeCarli, Charles; Fletcher, Evan M; Maillard, Pauline M; Barkhof, Frederik; Barnes, Josephine; Benke, Thomas; Chen, Christopher P L H; Dal-Bianco, Peter; Dewenter, Anna; Duering, Marco; Enzinger, Christian; Ewers, Michael; Exalto, Lieza G; Franzmeier, Nicolai; Hilal, Saima; Hofer, Edith; Koek, Huiberdina L; Maier, Andrea B; McCreary, Cheryl R; Papma, Janne M; Paterson, Ross W; Pijnenburg, Yolande A L; Rubinski, Anna; Schmidt, Reinhold; Schott, Jonathan M; Slattery, Catherine F; Smith, Eric E; Sudre, Carole H; Steketee, Rebecca M E; Teunissen, Charlotte E; van den Berg, Esther; van der Flier, Wiesje M; Venketasubramanian, Narayanaswamy; Venkatraghavan, Vikram; Vernooij, Meike W; Wolters, Frank J; Xin, Xu; Kuijf, Hugo J; Biessels, Geert Jan.
Affiliation
  • Biesbroek JM; Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, The Netherlands.
  • Coenen M; Department of Neurology, Diakonessenhuis Hospital, Utrecht, The Netherlands.
  • DeCarli C; Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, The Netherlands.
  • Fletcher EM; Department of Neurology, University of California at Davis, Davis, California, USA.
  • Maillard PM; Department of Neurology, University of California at Davis, Davis, California, USA.
  • Barkhof F; Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, The Netherlands.
  • Barnes J; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
  • Benke T; Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, UK.
  • Chen CPLH; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Dal-Bianco P; Clinic of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Dewenter A; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Duering M; Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore.
  • Enzinger C; Department of Neurology, Medical University Vienna, Vienna, Austria.
  • Ewers M; Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, München, Germany.
  • Exalto LG; Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, München, Germany.
  • Franzmeier N; Medical Image Analysis Center (MIAC) and Department of Biomedical Engineering, University of Basel, Basel, Switzerland.
  • Hilal S; Division of General Neurology, Department of Neurology, Medical University Graz, Graz, Austria.
  • Hofer E; Division of Neuroradiology, Interventional and Vascular Radiology, Department of Radiology, Medical University of Graz, Graz, Austria.
  • Koek HL; Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, München, Germany.
  • Maier AB; Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, The Netherlands.
  • McCreary CR; Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, München, Germany.
  • Papma JM; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Paterson RW; Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore.
  • Pijnenburg YAL; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.
  • Rubinski A; Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.
  • Schmidt R; Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
  • Schott JM; Department of Geriatric Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Slattery CF; Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore.
  • Smith EE; Department of Medicine, National University of Singapore, Singapore, Singapore.
  • Sudre CH; Departments of Clinical Neurosciences and Radiology and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
  • Steketee RME; Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Teunissen CE; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • van den Berg E; Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • van der Flier WM; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Venketasubramanian N; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Venkatraghavan V; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
  • Vernooij MW; Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, München, Germany.
  • Wolters FJ; Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.
  • Xin X; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Kuijf HJ; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Biessels GJ; Departments of Clinical Neurosciences and Radiology and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Alzheimers Dement ; 20(4): 2980-2989, 2024 04.
Article in En | MEDLINE | ID: mdl-38477469
ABSTRACT

INTRODUCTION:

White matter hyperintensities (WMH) are associated with key dementia etiologies, in particular arteriolosclerosis and amyloid pathology. We aimed to identify WMH locations associated with vascular risk or cerebral amyloid-ß1-42 (Aß42)-positive status.

METHODS:

Individual patient data (n = 3,132; mean age 71.5 ± 9 years; 49.3% female) from 11 memory clinic cohorts were harmonized. WMH volumes in 28 regions were related to a vascular risk compound score (VRCS) and Aß42 status (based on cerebrospinal fluid or amyloid positron emission tomography), correcting for age, sex, study site, and total WMH volume.

RESULTS:

VRCS was associated with WMH in anterior/superior corona radiata (B = 0.034/0.038, p < 0.001), external capsule (B = 0.052, p < 0.001), and middle cerebellar peduncle (B = 0.067, p < 0.001), and Aß42-positive status with WMH in posterior thalamic radiation (B = 0.097, p < 0.001) and splenium (B = 0.103, p < 0.001).

DISCUSSION:

Vascular risk factors and Aß42 pathology have distinct signature WMH patterns. This regional vulnerability may incite future studies into how arteriolosclerosis and Aß42 pathology affect the brain's white matter. HIGHLIGHTS Key dementia etiologies may be associated with specific patterns of white matter hyperintensities (WMH). We related WMH locations to vascular risk and cerebral Aß42 status in 11 memory clinic cohorts. Aß42 positive status was associated with posterior WMH in splenium and posterior thalamic radiation. Vascular risk was associated with anterior and infratentorial WMH. Amyloid pathology and vascular risk have distinct signature WMH patterns.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dementia / Arteriolosclerosis / White Matter Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Alzheimers Dement Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dementia / Arteriolosclerosis / White Matter Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Alzheimers Dement Year: 2024 Document type: Article